Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.1.1 (
hexokinase
)
5,274
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In rabbit reticulocytes, the
hexokinase
(
EC 2.7.1.1
)-specific activity is 4-5 times that of corresponding mature red cells. Immunoprecipitation of
hexokinase
by a polyclonal antibody made in vitro shows that this maturation-dependent
hexokinase
decay is not due to accumulation of inactive enzyme molecules but to degradation of
hexokinase
. A cell-free system derived from rabbit reticulocytes, but not mature erythrocytes, was found to catalyze the decay of hexokinae activity and the degradation of 125I-labeled enzyme. This degradation is ATP-dependent and requires both ubiquitin and a proteolytic fraction retained by DEAE-cellulose. Maximum ATP-dependent degradation was obtained at pH 7.5 in the presence of MgATP. MgGTP could replace MgATP with a relative stimulation of 0.90. 125I-Hexokinase incubated with reticulocyte extract in the presence of ATP forms high molecular weight aggregates that reach a steady-state concentration in 1 h, whereas the degradation of the enzyme is linear up to 8 h, suggesting that the formation of protein aggregates precedes enzyme catabolism. These aggregates are stable upon boiling in 2% sodium dodecyl sulfate, 3% mercaptoethanol and probably represent an intermediate step in the enzyme degradation with
hexokinase
and other proteins covalently conjugate to ubiquitin. That
hexokinase
could be conjugated to ubiquitin was shown by the formation of 125I-ubiquitin-
hexokinase
complexes in the presence of ATP and the enzymes of the
ubiquitin-protein ligase
system. Thus, the decay of
hexokinase
during reticulocyte maturation is ATP- and ubiquitin-dependent and suggests a new physiological role for the energy-dependent degradation system of reticulocytes.
...
PMID:Rabbit red blood cell hexokinase. Decay mechanism during reticulocyte maturation. 301 48
In rabbit erythrocytes
hexokinase
(
EC 2.7.1.1
) specific activity is 4-5 times that of corresponding mature red cells. Immunoprecipitation of
hexokinase
by an in vitro made policlonal antibody shows that this maturation dependent
hexokinase
decay is not due to the accumulation of inactive enzyme molecules but to degradation of
hexokinase
. A cell-free system made from rabbit reticulocytes, but not mature erythrocytes, was found to catalyze the decay of
hexokinase
activity and the degradation of 125I-labeled enzyme. This degradation is ATP-dependent and requires both ubiquitin and a proteolytic fraction retained by DEAE-cellulose. 125I-
hexokinase
incubated with reticulocyte extract in the presence of ATP forms high molecular weight aggregates. These aggregates are stable upon boiling in 2% sodium dodecyl sulfate, 3% mecaptoethanol and probably represent an intermediate step in the enzyme degradation with
hexokinase
and other proteins covalently conjugate to ubiquitin. That
hexokinase
could be conjugate to ubiquitin was shown by the formation of 125I-ubiquitin-
hexokinase
complexes in the presence of ATP and the enzymes of the
ubiquitin-protein ligase
system. Thus, the decay of
hexokinase
during reticulocyte maturation is ATP and ubiquitin dependent and involves both the
hexokinase
molecular forms (
hexokinase
Ia and Ib) present in reticulocytes. "In vivo",
hexokinase
Ia is mitochondrial bound while
hexokinase
Ib is soluble. The energy dependent degradation system of reticulocytes is active only on the soluble enzyme, namely
hexokinase
Ib. As the cell mature mitochondria are degradated,
hexokinase
Ia becomes soluble but there is a concomitant decay also of the proteolytic system resulting in a mature erythrocyte that contains only
hexokinase
Ia in a soluble form.
...
PMID:Decay mechanisms of rabbit hexokinase during reticulocyte maturation. 359 95